Pentobarbital sodium legal status controlled substance?

See the DrugPatentWatch profile for Pentobarbital

What makes Pentobarbital sodium a controlled substance?

Pentobarbital sodium, a barbiturate with sedative properties, has been classified as a Schedule II controlled substance in many countries. This scheduling indicates that it has a potential for abuse, but also recognized medical use with acceptable risk.

Why was Pentobarbital sodium rescheduled?

In 1965, the Drug Abuse Control Amendments recategorized Pentobarbital sodium from a Schedule II to a Schedule II(n) substance, which added more restrictions on its prescription and use. This change was due to increasing concerns about its potential for abuse and dependence.

What happened in 1970?

The Controlled Substances Act of 1970 further reclassified Pentobarbital sodium as a Schedule III substance. Although it still had limitations on its use, it was no longer as tightly regulated as previously.

Who oversees the use of Pentobarbital sodium?

The U.S. DEA (Drug Enforcement Administration) and other regulatory agencies continue to monitor and manage the distribution and use of Pentobarbital sodium to ensure compliance with controlled substance laws.

Is Pentobarbital sodium still used today?

Yes, despite its controlled status, Pentobarbital sodium is still being used in various medical applications, such as for its sedative effects in certain medical procedures or for end-of-life care.

Sources:
[1] Drug Enforcement Administration, United States Department of Justice. (n.d.). Drug Scheduling. Retrieved from https://www.dea.gov/drug-scheduling
[2] National Institute on Drug Abuse. (n.d.). Barbiturates. Retrieved from https://www.drugabuse.gov/publications/research-reports/barbiturates
[3] International Narcotics Control Board. (n.d.). International Narcotics Control Board Reports. Retrieved from https://www.incb.org/incb/en/annual-reports-to-the-united-nations-general assembly.html